Patents Assigned to Oasis Pharmaceuticals, LLC
  • Protease-activated receptor-2 modulators
    Patent number: 11732027
    Abstract: Provided herein are peptides comprising a mutated fragment of a wild-type protease-activated receptor-2 (PAR2). The peptides comprising a hydrophobic moiety can penetrate the cell membrane and act as an antagonist of PAR2. Also provided herein are compositions and cells comprising the peptides and methods of using the peptides.
    Type: Grant
    Filed: July 10, 2020
    Date of Patent: August 22, 2023
    Assignee: Oasis Pharmaceuticals, LLC
    Inventor: Richard J. Looby
  • Protease-activated receptor-2 modulators
    Patent number: 11091533
    Abstract: Provided herein are peptides comprising a mutated fragment of a wild-type protease-activated receptor-2 (PAR2). The peptides comprising a hydrophobic moiety can penetrate the cell membrane and act as an antagonist of PAR2. Also provided herein are compositions and cells comprising the peptides and methods of using the peptides.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: August 17, 2021
    Assignee: Oasis Pharmaceuticals, LLC
    Inventor: Richard Looby
  • PROTEASE-ACTIVATED RECEPTOR-2 MODULATORS
    Publication number: 20210061883
    Abstract: Provided herein are peptides comprising a mutated fragment of a wild-type protease-activated receptor-2 (PAR2). The peptides comprising a hydrophobic moiety can penetrate the cell membrane and act as an antagonist of PAR2. Also provided herein are compositions and cells comprising the peptides and methods of using the peptides.
    Type: Application
    Filed: July 10, 2020
    Publication date: March 4, 2021
    Applicant: Oasis Pharmaceuticals, LLC
    Inventor: Richard J. Looby